+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Santen - logo

Santen Pharmaceutical engages in the research, development, manufacture, and marketing of ophthalmic products covering a range of conditions, from allergy and infection to glaucoma. The company offers prescription and over-the-counter products for the treatment of eye and rheumatic diseases. Its products comprise IQUIX, Quixin, Betimo and Alamast. The company was founded in 1890 and is based in Japan.

Investor Series: Opportunities in the Cell and Gene Therapy Market - Product Thumbnail Image

Investor Series: Opportunities in the Cell and Gene Therapy Market

  • Report
  • April 2022
  • 121 Pages
  • Global
From
AI-based Drug Discovery Market: Distribution by Drug Discovery Steps, Therapeutic Area and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

AI-based Drug Discovery Market: Distribution by Drug Discovery Steps, Therapeutic Area and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • April 2022
  • 334 Pages
  • Global
From
Betaxolol Market - Global Forecast 2025-2030 - Product Thumbnail Image

Betaxolol Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 188 Pages
  • Global
From
Eye Mite Solutions Market - Global Forecast 2025-2030 - Product Thumbnail Image

Eye Mite Solutions Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 181 Pages
  • Global
From
Eylea Market Report 2025 - Product Thumbnail Image

Eylea Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030 - Product Thumbnail Image

Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030

  • Report
  • February 2020
  • 240 Pages
  • Global
From
Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Hypertension - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Breast Cancer Therapeutics Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Breast Cancer Therapeutics Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2023
  • 120 Pages
  • Global
From
Alpha Mannosidosis Market Report 2025 - Product Thumbnail Image

Alpha Mannosidosis Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Distribution Deals in Medical Devices 2016 to 2025 - Product Thumbnail Image

Distribution Deals in Medical Devices 2016 to 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Cell and Gene Therapy Market Report 2025 - Product Thumbnail Image

Cell and Gene Therapy Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Epinastine HCL Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Epinastine HCL Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • February 2024
  • 92 Pages
  • Global
From
Vitreoretinal Surgery Devices Market - Global Forecast 2025-2032 - Product Thumbnail Image

Vitreoretinal Surgery Devices Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 181 Pages
  • Global
From
Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • July 2023
  • 229 Pages
  • Global
From
AI Opportunities in Personalised Medicine - Product Thumbnail Image

AI Opportunities in Personalised Medicine

  • Report
  • March 2023
  • Global
From
UK Pharmaceutical Manufacturers & Distributors - Industry Report - Product Thumbnail Image

UK Pharmaceutical Manufacturers & Distributors - Industry Report

  • Report
  • November 2025
  • 550 Pages
  • United Kingdom
From
Canada General Surgical Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Canada General Surgical Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 70 Pages
  • Canada
From
North America Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 111 Pages
  • North America
From
Europe Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Europe
From
LAMEA Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Middle East, Africa
From
Loading Indicator